AAAAAA
Results:
1-17
|
Results: 17
Authors:
GOLDBERG JM
PIVER MS
HEMPLING RE
AIDUK C
BLUMENSON L
RECIO FO
Citation: Jm. Goldberg et al., IMPROVEMENTS IN PELVIC EXENTERATION - FACTORS RESPONSIBLE FOR REDUCING MORBIDITY AND MORTALITY, Annals of surgical oncology, 5(5), 1998, pp. 399-406
Authors:
RECIO FO
SRIVASTAVA BIS
WONG C
HEMPLING RE
ELTABBAKH GH
PIVER MS
Citation: Fo. Recio et al., THE CLINICAL-VALUE OF DIGENE HYBRID CAPTURE HPV DNA TESTING IN A REFERRAL-BASED POPULATION WITH ABNORMAL PAP SMEARS, European journal of gynaecological oncology, 19(3), 1998, pp. 203-208
Authors:
PIVER MS
ELTABBAKH GH
HEMPLING RE
RECIO FO
BLUMENSON LE
Citation: Ms. Piver et al., PROSPECTIVE SEQUENTIAL TRIALS OF INDUCTION WEEKLY CISPLATIN FOLLOWED BY MONTHLY CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE AND PACLITAXEL ANDCISPLATIN IN OPTIMAL (LESS-THAN-OR-EQUAL-TO-1 CM) STAGE-III AND STAGE-IV OVARIAN-CANCER, European journal of gynaecological oncology, 19(1), 1998, pp. 5-10
Authors:
RECIO FO
PIVER MS
HEMPLING RE
ELTABBAKH GH
HAHN S
Citation: Fo. Recio et al., LAPAROSCOPIC-ASSISTED APPLICATION OF INTERSTITIAL BRACHYTHERAPY FOR LOCALLY ADVANCED CERVICAL-CARCINOMA - RESULTS OF A PILOT-STUDY, International journal of radiation oncology, biology, physics, 40(2), 1998, pp. 411-414
Authors:
SILVER DF
HEMPLING RE
PIVER MS
RECIO FO
ELTABBAKH GH
Citation: Df. Silver et al., STAGE-I ADENOCARCINOMA OF THE CERVIX - DOES LESION SIZE AFFECT TREATMENT OPTIONS AND PROGNOSIS, American journal of clinical oncology, 21(5), 1998, pp. 431-435
Authors:
HEMPLING RE
PIVER MS
ELTABBAKH GH
RECIO FO
Citation: Re. Hempling et al., PROGESTERONE-RECEPTOR STATUS IS A SIGNIFICANT PROGNOSTIC VARIABLE OF PROGRESSION-FREE SURVIVAL IN ADVANCED EPITHELIAL OVARIAN-CANCER, American journal of clinical oncology, 21(5), 1998, pp. 447-451
Authors:
SILVER DF
HEMPLING RE
RECIO FO
PIVER MS
ELTABBAKH GH
Citation: Df. Silver et al., COMPLICATIONS RELATED TO INDWELLING CAVAL CATHETERS ON A GYNECOLOGIC ONCOLOGY SERVICE, Gynecologic oncology (Print), 70(3), 1998, pp. 329-333
Authors:
ELTABBAKH GH
PIVER MS
HEMPLING RE
RECIO FO
LELE SB
MARCHETTI DL
BAKER TR
BLUMENSON LE
Citation: Gh. Eltabbakh et al., CORRELATION BETWEEN EXTREME DRUG-RESISTANCE ASSAY AND RESPONSE TO PRIMARY PACLITAXEL AND CISPLATIN IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER, Gynecologic oncology (Print), 70(3), 1998, pp. 392-397
Authors:
RECIO FO
PIVER MS
HEMPLING RE
DRISCOLL DL
Citation: Fo. Recio et al., 5-YEAR SURVIVAL AFTER 2ND-LINE CISPLATIN-BASED INTRAPERITONEAL CHEMOTHERAPY FOR ADVANCED OVARIAN-CANCER, Gynecologic oncology, 68(3), 1998, pp. 267-273
Authors:
ELTABBAKH GH
HEMPLING RE
RECIO FO
ONEILL CP
Citation: Gh. Eltabbakh et al., REMARKABLE RESPONSE OF PRIMARY SQUAMOUS-CELL CARCINOMA OF THE OVARY TO PACLITAXEL AND CISPLATIN, Obstetrics and gynecology, 91(5), 1998, pp. 844-846
Authors:
HEMPLING RE
ELTABBAKH GH
PIVER MS
RECIO FO
ONEILL CP
Citation: Re. Hempling et al., THE ADDITION OF BLEOMYCIN AND DOSE-ESCALATED IFOSFAMIDE TO THE COMBINATION OF CISPLATIN PLUS IFOSFAMIDE DOES NOT IMPROVE SURVIVAL IN ADVANCED OR RECURRENT CERVICAL-CARCINOMA, American journal of clinical oncology, 20(3), 1997, pp. 315-318
Authors:
PIVER MS
ELTABBAKH GH
HEMPLING RE
RECIO FO
BLUMENSON LE
Citation: Ms. Piver et al., 2 SEQUENTIAL STUDIES FOR PRIMARY PERITONEAL CARCINOMA - INDUCTION WITH WEEKLY CISPLATIN FOLLOWED BY EITHER CISPLATIN-DOXORUBICIN-CYCLOPHOSPHAMIDE OR PACLITAXEL-CISPLATIN, Gynecologic oncology, 67(2), 1997, pp. 141-146
Authors:
LOREE TR
HEMPLING RE
ELTABBAKH GH
RECIO FO
PIVER MS
Citation: Tr. Loree et al., THE INFERIOR GLUTEAL FLAP IN THE DIFFICULT VULVAR AND PERINEAL RECONSTRUCTION, Gynecologic oncology, 66(3), 1997, pp. 429-434
ESTROGEN REPLACEMENT THERAPY FOLLOWING OOPHORECTOMY IN WOMEN WITH A FAMILY HISTORY OF OVARIAN-CANCER
Authors:
ELTABBAKH GH
PIVER MS
HEMPLING RE
RECIO FO
AIDUK C
Citation: Gh. Eltabbakh et al., ESTROGEN REPLACEMENT THERAPY FOLLOWING OOPHORECTOMY IN WOMEN WITH A FAMILY HISTORY OF OVARIAN-CANCER, Gynecologic oncology, 66(1), 1997, pp. 103-107
Authors:
GOLDBERG JM
PIVER MS
HEMPLING RE
RECIO FO
Citation: Jm. Goldberg et al., PACLITAXEL AND CISPLATIN COMBINATION CHEMOTHERAPY IN RECURRENT EPITHELIAL OVARIAN-CANCER, Gynecologic oncology, 63(3), 1996, pp. 312-317
Authors:
RECIO FO
PIVER MS
HEMPLING RE
Citation: Fo. Recio et al., PRETREATMENT TRANSPERITONEAL LAPAROSCOPIC STAGING PELVIC AND PARAAORTIC LYMPHADENECTOMY IN LARGE (GREATER-THAN-OR-EQUAL-TO-5 CM) STAGE IB2 CERVICAL-CARCINOMA - REPORT OF A PILOT-STUDY, Gynecologic oncology, 63(3), 1996, pp. 333-336
Authors:
PIVER MS
RECIO FO
BAKER TR
DRISCOLL D
Citation: Ms. Piver et al., EVALUATION OF SURVIVAL AFTER 2ND-LINE INTRAPERITONEAL CISPLATIN-BASEDCHEMOTHERAPY FOR ADVANCED OVARIAN-CANCER, Cancer, 73(6), 1994, pp. 1693-1698
Risultati:
1-17
|